TG Therapeutics Inc

NASDAQ:TGTX   3:59:59 PM EDT
29.32
-0.97 (-3.20%)
Earnings Announcements

Tg Therapeutics Provides Business Update And Reports Third Quarter 2020 Financial Results

Published: 11/09/2020 23:10 GMT
TG Therapeutics Inc (TGTX) - Tg Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results.
Tg Therapeutics Inc- Qtrly Loss per Share $0.73.
Tg Therapeutics - Believes Cash, Cash Equivalents on Hand As of Sept.
30, 2020, Will Be Sufficient to Fund Co's Planned Operations Well Into 2022.
Revenue is expected to be $0.02 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.